Literature DB >> 18259204

Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis.

O Backhouse, K J Bhan, F Bishop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18259204     DOI： 10.1038/eye.2008.5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

Review 1.  Ocular toxoplasmosis II: clinical features, pathology and management.

Authors:  Nicholas J Butler; João M Furtado; Kevin L Winthrop; Justine R Smith
Journal:  Clin Exp Ophthalmol       Date:  2012-09-17       Impact factor: 4.207

2.  Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration.

Authors:  Ryan Rush; Saumil Sheth
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848

3.  Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma Therapy versus Intravitreal Therapy Alone in the Management of Toxoplasma Retinochoroiditis: A Retrospective Study.

Authors:  Ashraf Bor'i; Ashraf Mahrous; Mahmoud A Al-Aswad; Haitham Y Al-Nashar; Waled M Nada; Mostafa Wagih; Ahmed M B Awad; Wael M El-Haig
Journal:  J Ophthalmol       Date:  2018-02-12       Impact factor: 1.909

4.  Toxoplasma retinitis following intravitreal injection of triamcinolone acetonide: A case report and review of literature.

Authors:  Arshee Ahmed; Sridharan Sudharshan; Sriram Gopal; Parthopratim Dutta Majumder; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2018-08       Impact factor: 1.848
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.